{
    "SPADE_UN_16926": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_16926",
            "Peptide Name": "VIH-Buforin-2 (5-21), VIH-sh-Buforin",
            "Source": "Synthetic",
            "Family": "",
            "Gene": "Not found",
            "Sequence": "VIHRAGLQFPVGRVHRLLRK",
            "Sequence Length": 20,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/P55897"
            ],
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Anticancer"
            ],
            "Target Organism": "Not available",
            "Hemolytic Activity": "Not available",
            "Cytotoxicity": "Not available",
            "Binding Target": "Not available",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C107H182N38O22",
            "Mass": 2352.83,
            "PI": 12.0,
            "Net Charge": 7,
            "Hydrophobicity": -0.06,
            "Half Life": "Mammalian:100 hourYeast:>20 hourE.coli:>10 hour",
            "Literature": [
                {
                    "Title": "Hybrid peptide ATCUN-sh-Buforin Influence of the ATCUN charge and stereochemistry on antimicrobial activity",
                    "Pubmed ID": "25891844",
                    "Reference": "Biochimie. 2015 Jun;113143-55.",
                    "Author": "Libardo MD, Paul TJ, Prabhakar R, Angeles-Boza AM.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=25891844"
                },
                {
                    "Title": "Improved bioactivity of antimicrobial peptides by addition of amino-terminal copper and nickel (ATCUn) binding motifs",
                    "Pubmed ID": "",
                    "Author": "Libardo MD, Cervantes JL, Salazar JC, Angeles-Boza AM"
                }
            ],
            "Frequent Amino Acids": "RLV",
            "Absent Amino Acids": "CDEMNOSTUWY",
            "Basic Residues": 7,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 10,
            "Polar Residues": 12,
            "Positive Residues": 7,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_08594",
                    "Similarity": 1.0,
                    "Sequence": "RAGLQFPVGRVHRLLR"
                },
                {
                    "SPADE_ID": "SPADE_N_08595",
                    "Similarity": 1.0,
                    "Sequence": "RAGLQFPVGRVHRLL"
                },
                {
                    "SPADE_ID": "SPADE_N_08596",
                    "Similarity": 1.0,
                    "Sequence": "RAGLQFPVGRVHRL"
                }
            ]
        }
    }
}